UBS Conference Roundup: Roche; Waters; Cepheid; Thermo Fisher Scientific; Bruker; Affymetrix; Qiagen; Myriad Genetics; Celera; Genzyme | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – This week executives from several firms in the molecular research tools and molecular diagnostics fields made their pitch to investors at the annual UBS Global Life Sciences Conference held here.

Below are snapshots from those firms' presentations and question-and-answer sessions.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.